An AI-designed drug changed six aging clocks

Newsletters Dark mode

Early human data point to a new model for longevity research.

to the archive

Sunday, September 20, 2026

Elysium Health promotes the latest edition of The Abstract, a newsletter discussing recent scientific discoveries on healthy aging. The issue highlights an AI-designed drug that affects six biological aging clocks and explores the potential of GLP-1 drugs, such as semaglutide, to slow aging. The newsletter coincides with Healthy Aging Month, focusing on preserving health and function with age.

Read this email as text

for screen readers, or when images don't load

Thanks for reading The Abstract. This month’s edition is 1,176 words, about a 4-minute read.

Is there a topic that you’d like to see more of in The Abstract? Drop us a line at [email protected]. Want to get The Abstract in your inbox? Sign up here.

September is Healthy Aging Month—a fitting time to ask not only how long we can live, but how science might help us preserve health and function along the way. In this edition of The Abstract: an AI-designed drug moves six biological aging clocks, semaglutide reveals effects in older mice that calorie restriction alone cannot explain, three minutes of sprinting transforms the molecular landscape of the blood, “intrinsic capacity” emerges as a potential measure of healthspan, and a large study connects the timing of our first meal with longevity.

Could GLP-1 drugs slow aging?

Email headers

sender, ESP fingerprints, unsubscribe and auth headers

As received, minus the delivery side: the archive's own addresses appear as [recipient], relay hops and signatures are left out, and unsubscribe links are trimmed to their host.

Received-SPF: pass ([receiver]: domain of [recipient]@send.elysiumhealth.com designates 149.72.85.18 as permitted sender) receiver=[receiver]; client-ip=149.72.85.18; envelope-from="[recipient]@send.elysiumhealth.com"; helo=o1409.shared.klaviyomail.com;
Authentication-Results: [receiver]; dkim=pass header.d=elysiumhealth.com header.s=kl2 header.b=dIAjiPzw; dmarc=pass header.from=elysiumhealth.com policy.dmarc=quarantine; spf=none ([receiver]: no SPF records found for [email protected]) smtp.helo=o1409.shared.klaviyomail.com; spf=pass ([receiver]: domain of [recipient]@send.elysiumhealth.com designates 149.72.85.18 as permitted sender) smtp.mailfrom=[recipient]@send.elysiumhealth.com; arc=none smtp.remote-ip=149.72.85.18
Content-Type: multipart/alternative; boundary=b03f057fc0b495493ed7512bf5481d9aa709325f7e1e75567488358f6367
Date: Sun, 20 Sep 2026 16:15:52 +0000 (UTC)
From: Elysium Abstract <[email protected]>
Mime-Version: 1.0
Message-ID: <l24f_hDLR_WJnYaeN1Y1bg@geopod-ismtpd-23>
Subject: An AI-designed drug changed six aging clocks
Reply-To: [email protected]
List-Unsubscribe: <https://manage.kmail-lists.com/…>
List-Unsubscribe-Post: List-Unsubscribe=One-Click
X-Kmail-Account: R8xQKv
X-Kmail-Message: 01M2REK2N27VWE7PDWFS2X55VJ
X-Kmail-Ops: 01KX28G5HSKQA9CNV085MJW4AC
X-Report-Abuse: Please report any spam or abuse to: [email protected]
X-SG-EID: u001.Xv32TvI6iuV+tZ4vlqHO3HOP0TVxYBknYAX4/Mby5Th0PYwVlaUDVZEfaaXcBa1/i/If+231cWgIYCosFVQxSLK8beGmxam/pyyAhG2qbCIqtru5T0awMF7jdYOX3/CPCbEmvmVzNesvvA0s22LdgNyBATmnqLk0HLwT1vM+b1cMVeEnC8ITa9r36xMbEa/MppGHnANFCi8VBGFyseL9yaaQYuc+AzgvjhV8/AcGffDVL17I+Bcx5wNeDc7wVf2v
X-SG-ID: u001.SdBcvi+Evd/bQef8eZF3BiU3Zi1S53GtqGa3TWBmqe75yn5aYrkvkfG+ZGKrHRvqHEqNnYhXzKEMbIPUuNbUdfpjphyJI24ahdp5cMyD+gtd10HMsYQGG+9KCgoFZ++5UZvSqdUXal4OX1ytPFxSx6BvvV6DEnIgR0+flOuf6fG19/qwvrgNlmodoX/5tWulDYetKoTB4ewVzPwYIPPgC50FKK+XvaSgOn234YIiaUAs2FHfrHcGzhsJkQSqsmDvGSKwYt0sGkXFjA+d8+JyifP9qRqPwEk9uYp4SB8+HEKyi4E2Hu9zj2THaFeYMzODY0FOvG5/TdMsDt3DoL+dcc+gOSYphhD/y2eQO2QlTEK1V3/uVWy3gfWx0Rmc86RE
X-Entity-ID: u001.lP8bpbcNOc7n5/pI/ei+9g==

Archived for reference and commentary. Elysium Health, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.